Human umbilical cord mesenchymal stem cells polarize RAW264.7 macrophages to an anti-inflammatory subpopulation

Yu Xu1, Hongxing Luo1, Fang Chen1

  • 1Department of Cardiology, Zhengzhou University People's Hospital Zhengzhou, Henan, China.

Abstract

Insights

Human umbilical cord mesenchymal stem cells (hUCMSCs) shift pro-inflammatory macrophages towards an anti-inflammatory state. This study shows hUCMSCs reduce inflammatory markers like iNOS and PGE2 in stimulated macrophages.

Area of Science:

  • Immunology
  • Stem Cell Biology

Background:

  • Macrophages play a critical role in immune responses.
  • Lipopolysaccharide (LPS) stimulation induces pro-inflammatory M1 macrophage polarization.
  • Mesenchymal stem cells (MSCs) possess immunomodulatory properties.

Purpose of the Study:

  • To investigate the immunomodulatory effects of human umbilical cord mesenchymal stem cells (hUCMSCs) on lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages.
  • To determine if hUCMSCs can alter macrophage polarization.
  • To assess the impact of hUCMSCs on inflammatory mediator production.

Main Methods:

  • RAW264.7 macrophages were stimulated with LPS and co-cultured with hUCMSCs using a Transwell system.
  • Flow cytometry was employed to analyze macrophage surface markers (F4/80, CD86, CD206).
  • Enzyme-linked immunosorbent assay (ELISA) measured prostaglandin E2 (PGE2) levels, and inducible nitric oxide synthase (iNOS) expression was quantified.

Main Results:

  • hUCMSCs significantly increased the population of F4/80+CD86+CD206+ macrophages.
  • hUCMSCs dose-dependently inhibited PGE2 secretion from LPS-stimulated macrophages.
  • hUCMSCs significantly reduced the expression of iNOS, a marker of M1 macrophages.

Conclusions:

  • hUCMSCs effectively polarize LPS-stimulated RAW264.7 macrophages towards an intermediate M2-like phenotype.
  • This polarization is associated with decreased levels of pro-inflammatory mediators, iNOS and PGE2.
  • hUCMSCs exhibit potential as a therapeutic agent for modulating inflammatory responses.